Thu, Aug 21, 2014, 8:53 AM EDT - U.S. Markets open in 37 mins.

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • a1ag a1ag Feb 25, 2013 9:31 AM Flag

    HUD-IDE-HDE all different

    Some easier ways to look at these terms (obviously its much deeper but this is a short version)
    InVivo has applied for HUD approval and FDA has 45 days to respond and if they request any additional information this resets the 45 days and the company might need trial info or other info that could take time to gather and re-submit.

    HUD- Company needs to show the product is needed for a population of 4,000 or less FDA will approve, Reject or ask for more information inside of 45 days of the HUD submission.

    IDE- This gives the company permission to start a Human Clinical Trial

    HDE- This gives the company an approval of the clinical trial.

    For and HDE and only and HDE the company only needs to prove the product is SAFE its does NOT need to prove efficacy. All other submissions IND NDA PMA etc.. need to prove efficacy.. HDE does NOT.

    You could start an IDE clinical Trial before you get HUD or even submit for and HUD. InVivo has gone for the HUD first based on guidance from FDA in 2012.

    Hope this helps. Looking for HUD approval soon! 56 products have been HDE approved since 2006 and getting HUD / HDE approval will move NVIV very fast!

    FDA does not post HUD approvals at all.

    all of this is on the FDA site.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It appears like HUD is the lowest hurdle. However, NVIV cannot get HUD in a timely manner (filed on Dec 14 and meet with the FDA in 2012 regarding a HUD designation). Does not bode well for starting clinical trials anytime soon.

      Sentiment: Hold

      • 1 Reply to jonesallen234
      • I agree on the surface but the facts are they submitted the IDE and then had such great potential then went from one location to the new state of the art facility they have and they can now produce the scaffold in-house. Clean room in-house etc.. this delay is only because they moved to a bigger newer facility. I have zero patience but this only makes sense to give it some time and this will take off fast.. they have a lot of people watching and this is a visual device that lets people see the results.

        Sentiment: Strong Buy

    • chrisandy@bellsouth.net chrisandy Feb 25, 2013 10:24 AM Flag

      If FDA does not post HUD approvals, then can company sit on this info?

      Sentiment: Buy

 
NVIV
0.67-0.03(-4.67%)Aug 20 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.